Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice
Authors:
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 203, 52-62
Abstract
No abstract availableKeywords
Funding Information
- IPF
- Pulmonary Fibrosis Foundation
- NIH
- AHA
- CVI
- American Heart Association
- Pulmonary Hypertension Association
This publication has 57 references indexed in Scilit:
- Reduction of intraoperative air leaks with Progel in pulmonary resection: a comprehensive reviewJournal of Cardiothoracic Surgery, 2013
- Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literatureEuropean Respiratory Review, 2012
- Current and novel drug therapies for idiopathic pulmonary fibrosisDrug Design, Development and Therapy, 2012
- Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44Journal of Experimental Medicine, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Resistance to Bleomycin-Induced Lung Fibrosis in MMP-8 Deficient Mice Is Mediated by Interleukin-10PLOS ONE, 2010
- Hyaluronidase Expression and Activity Is Regulated by Pro-Inflammatory Cytokines in Human Airway Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF- in the lungThorax, 2006
- Effect of Interleukin-10 on the Gene Expression of Type I Collagen, Fibronectin, and Decorin in Human Skin Fibroblasts: Differential Regulation by Transforming Growth Factor-β and Monocyte Chemoattractant Protein-1Biochemical and Biophysical Research Communications, 2001